The Competition Commission of India has approved the acquisition of additional share capital of Agilus Diagnostics Limited ...

Fortis Healthcare has received CCI approval to acquire an additional 31.52% stake in Agilus Diagnostics for Rs 1,780 crore, ...

The Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in ...

CCI approves Fortis Healthcare's acquisition of Agilus Diagnostics, Diligent Power-DB Power merger, and Thoughtworks Holding ...

The Competition Commission of India has approved the acquisition of additional share capital of Agilus Diagnostics Limited (Agilus) by Fortis Healthcare Limited (FHL)The Proposed Combination involves ...

Mumbai: Agilus Diagnostics announces the launch of its Pharmacogenomics Testing Service. The service empowers healthcare providers and patients with vital insights into how individual genetic ...

Fortis Healthcare gains regulatory clearance for acquiring an additional 31.52% stake in Agilus Diagnostics, increasing its total share to 89.2%. Simultaneously, the Competition Commission of India ...

New Delhi: The competition watchdog CCI on Tuesday approved Fortis Healthcare's proposal to acquire an additional 31.52 per cent stake in Agilus Diagnostics. Multi-speciality hospital chain Fortis ...

Agilus Diagnostics on Monday announced the launch of its pharmacogenomics testing service in India. According to the company’s press statement, this innovative service empowers healthcare ...